Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
SIMVASTATIN
Alcohol Abuse
Anna Cruceta
P2/3
B
(57)
SIMVASTATIN
Fibrotic Liver Disease
Anna Cruceta
P2/3
B
(57)
Sirolimus
COVID-19
University of Chicago
P2/3
B
(57)
Sirolimus
Pulmonary Fibrosis
University of Chicago
P2/3
B
(57)
Sodium Lactate
Traumatic Brain Injury
University of California, Los Angeles
P2/3
B
(57)
Sonazoid
Head And Neck Cancer
The Netherlands Cancer Institute
P2/3
B
(57)
Sorafenib
Disease Related To Hematopoietic Stem Cell Transplant
Nanfang Hospital, Southern Medical University
P2/3
B
(57)
sph4336
Breast Cancer
Shanghai Pharmaceuticals Holding Co., Ltd
P2/3
B
(57)
st-02
Renal Pelvis/Ureter Urothelial Carcinoma
University of British Columbia
P2/3
B
(57)
SULFAMETHOXAZOLE
Non-Hodgkin Lymphoma
Monash University
P2/3
B
(57)
Talikabtagene Autoleucel
Follicular Lymphoma
Health Institutes of Turkey
P2/3
B
(57)
Talikabtagene Autoleucel
High Grade B-Cell Lymphoma
Health Institutes of Turkey
P2/3
B
(57)
Talikabtagene Autoleucel
Non-Hodgkin Lymphoma
Health Institutes of Turkey
P2/3
B
(57)
Tenecteplase
Acute Disease
ProMedica Health System
P2/3
B
(57)
Tenecteplase
Brain Disorder
University of Melbourne
P2/3
B
(57)
Tenecteplase
Central Nervous System Disorder
University of Melbourne
P2/3
B
(57)
Tiaoshen Anti-Cancer Granules
Ovarian Cancer
Shanghai Municipal Hospital of Traditional Chinese Medicine
P2/3
B
(57)
Tiaoshen Anti-Cancer Granules
Sleep Disorder, Initiating And Maintaining Sleep
Shanghai Municipal Hospital of Traditional Chinese Medicine
P2/3
B
(57)
Trametinib
Glioma
Cancer Research UK
P2/3
B
(57)
Trametinib
Plasma Cell Myeloma
Cancer Research UK
P2/3
B
(57)
TRASTUZUMAB
Ovarian Neoplasm
Cancer Research UK
P2/3
B
(57)
TRASTUZUMAB
Prostate Neoplasm
Cancer Research UK
P2/3
B
(57)
TRASTUZUMAB
Tumor Of Salivary Gland
Cancer Research UK
P2/3
B
(57)
TRASTUZUMAB
Skin Neoplasm
Cancer Research UK
P2/3
B
(57)
TRASTUZUMAB
Urinary Bladder Neoplasm
Cancer Research UK
P2/3
B
(57)
Showing 626 to 650 of 1,055 assets
Previous
Page 26 of 43
Next